Beatriz Martins

Artificially cloaked viral nanovaccine for cancer immunotherapy

Manlio Fusciello, Flavia Fontana, Siri Tähtinen et al. · Nature Communications · 2019 · 132 citations · Full text

FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis

S. Pauliina Turunen, Pernilla von Nandelstadh, Tiina Öhman et al. · Cell Death and Differentiation · 2019 · 63 citations · Full text

Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy

Siri Tähtinen, Sara Feola, Cristian Capasso et al. · Cancer Research · 2020 · 53 citations

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello et al. · Molecular Therapy — Oncolytics · 2021 · 51 citations · Full text

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text